Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

Determination of insulin resistance and its relationship with hyperandrogenemia, anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome

Pages
1117–1125
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FAI might be used as a supporting IR marker (definedby OGTT) in adolescent girls with PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study aims to investigate the association between polycystic ovary syndrome (PCOS) and obesity and insulinresistance (IR) with respect to anti-Müllerian hormone (AMH), inhibin A (INH-A), inhibin B (INH-B), and insulin-like peptide 3(INSL3) levels, all factors which may have an impact on IR.Materials and methods: In this cross sectional study, 52 adolescent girls diagnosed with PCOS [groups: nonobese (NO), n = 23;overweight/obese (OW/O), n = 29] were included.
📊
Key Findings & Data:Blood samples were obtained to measure AMH, INH-B, INH-A, and INSL3 levels,together with hormonal and biochemical assessments.
💡
Conclusion & Impact:FAI might be used as a supporting IR marker (definedby OGTT) in adolescent girls with PCOS.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: This study aims to investigate the association between polycystic ovary syndrome (PCOS) and obesity and insulinresistance (IR) with respect to anti-Müllerian hormone (AMH), inhibin A (INH-A), inhibin B (INH-B), and insulin-like peptide 3(INSL3) levels, all factors which may have an impact on IR.Materials and methods: In this cross sectional study, 52 adolescent girls diagnosed with PCOS [groups: nonobese (NO), n = 23;overweight/obese (OW/O), n = 29] were included. Blood samples were obtained to measure AMH, INH-B, INH-A, and INSL3 levels,together with hormonal and biochemical assessments. Oral glucose tolerance test (OGTT) was performed and the indexes of IR[homeostasis model assessment: insulin resistance (HOMA-IR) and Matsuda index] were calculated.Results: Insulin resistance was 56.5% with OGTT and 30.4% with HOMA-IR in nonobese-PCOS girls. There was a correlation betweenINH-A and HOMA-IR even when controlled for body mass index (BMI). INH-B and FAI also had correlations with HOMA-IR whichdisappeared when controlled for BMI. In regression analyses, AMH (odds ratio = [0.903, P = 0.015) and FAI (odds ratio = 1.353, P= 0.023) are found to be contributors to IR. Their effect was BMI-independent. In ROC analysis, the cutoff value for FAI was 5.93(sensitivity 71%) to define IR in PCOS girls.Conclusion: AMH and FAI may contribute to IR (defined by OGTT) in PCOS. FAI might be used as a supporting IR marker (definedby OGTT) in adolescent girls with PCOS.

🔖

Cite This Article

ŞAHİN, A. Y., UÇAR, A., YETİM, Ç., BUNDAK, R., POYRAZOĞLU, Ş., DARENDELİLER, F., BAŞ, F. (2022). Determination of insulin resistance and its relationship with hyperandrogenemia, anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 4, 1117–1125. https://ajindex.com/articles/609989

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity–a problem that is no longer restricted to minority groups. European Journal of Endocrinology 2004; 151(2): 199-206
  2. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Human Reproduction Update 2003; 9: 359-372. doi: 10.1093/humupd/ dmg024 3. Bronstein J, Tawdekar S, Liu Y, Pawelczak M, David R et al. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. Journal of Pediatric and Adolescent Gynecology 2011; 24: 15-20. doi: 10.1016/j.jpag.2010.06.003 4. Chung PW, Chan SSC, Yiu KW, Lao TTH, Chung TKH. Menstrual disorders in a Paediatric and Adolescent Gynaecology Clinic: patient presentations and longitudinal outcomes. Hong Kong Medical Journal 2011; 17: 391-397
  3. Li HW, Anderson RA, Yeung WS, Ho PC, Ng EH. Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertility and Sterility 2011; 96: 774-779. doi: 10.1016/j. fertnstert.2011.06.016 6. İliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can antiMullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. Journal of Clinical Endocrinology and Metabolism 2013; 98: 3332-3340. doi: 10.1210/jc.2013-1393 7. Gambineri A, Patton L, De Iasio R, Paladoro F, Pagotto U et al. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007; 92: 2066-2073. doi: 10.1210/jc.2006-1678 8. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B et al. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Fertility and Sterility 2000; 73: 972-977. doi: 10.1016/S0015-0282(00)00421-0 9. Segal S, Elmadjian M, Takeshiqe T, Karp S, Mercado R et al. Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reproductive BioMedicine Online 2010; 20: 675-680. doi: 10.1016/j.rbmo.2010.02.006 10. Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G et al. Anti-Müllerian hormone and inhibin A, but not inhibin B or insulin